These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

761 related items for PubMed ID: 21572152

  • 1. Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors.
    Goldfarb DS, MacDonald PA, Hunt B, Gunawardhana L.
    J Rheumatol; 2011 Jul; 38(7):1385-9. PubMed ID: 21572152
    [Abstract] [Full Text] [Related]

  • 2. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.
    Becker MA, Schumacher HR, Wortmann RL, MacDonald PA, Palo WA, Eustace D, Vernillet L, Joseph-Ridge N.
    Arthritis Rheum; 2005 Mar; 52(3):916-23. PubMed ID: 15751090
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA, Schumacher HR, MacDonald PA, Lloyd E, Lademacher C.
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
    Becker MA, Schumacher HR, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N.
    N Engl J Med; 2005 Dec 08; 353(23):2450-61. PubMed ID: 16339094
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Febuxostat for prevention of gout attacks.
    Pohar S, Murphy G.
    Issues Emerg Health Technol; 2006 Aug 08; (87):1-4. PubMed ID: 16958189
    [Abstract] [Full Text] [Related]

  • 20. Febuxostat: a new treatment for hyperuricaemia in gout.
    Edwards NL.
    Rheumatology (Oxford); 2009 May 08; 48 Suppl 2():ii15-ii19. PubMed ID: 19447778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.